Effects of time-of-day on inhibition of lens-induced myopia by quinpirole, pirenzepine and atropine in chicks

التفاصيل البيبلوغرافية
العنوان: Effects of time-of-day on inhibition of lens-induced myopia by quinpirole, pirenzepine and atropine in chicks
المؤلفون: Kelsey Jordan, Debora L. Nickla, Puneet Singh, Jane Yang
المصدر: Experimental Eye Research. 181:5-14
بيانات النشر: Elsevier BV, 2019.
سنة النشر: 2019
مصطلحات موضوعية: Atropine, Agonist, medicine.medical_specialty, Quinpirole, Evening, medicine.drug_class, medicine.medical_treatment, Muscarinic Antagonists, Eye, Drug Administration Schedule, Article, Cellular and Molecular Neuroscience, Internal medicine, Muscarinic acetylcholine receptor, Myopia, medicine, Animals, Saline, Morning, business.industry, Pirenzepine, Sensory Systems, Circadian Rhythm, Ophthalmology, Endocrinology, Animals, Newborn, Dopamine Agonists, Intravitreal Injections, Sensory Deprivation, business, Chickens, medicine.drug
الوصف: Injections of the D2 dopamine receptor agonist quinpirole or the acetylcholine muscarinic receptor antagonists pirenzepine and atropine prevent the development of negative-lens-induced myopia in chicks by inhibiting ocular growth. Because ocular growth is diurnally rhythmic, we hypothesized that the efficacy for inhibition may depend on time of day. Chicks wore monocular -10D lenses for 5 days, starting at 12d of age. The light cycle was 12L/12D. The lens-wearing eye received daily intravitreal injections for 4 days, of 20 μl quinpirole (10 nmol), at the following times: 7:30 EST (lights-on; morning; n = 12), 12:00 (mid-day; n = 13), or 19:30 (evening; n = 17). The same protocol was used for pirenzepine (0.2 μmol) and atropine (18 nmol), at the following times: 8:30 EDT (lights-on; n = 10; n = 18), 14:00 (n = 10; n = 12), or 20:30 (n = 18; n = 16). Saline injections were done in separate groups of birds for all groups as controls, and the data combined (n = 28). Ocular dimensions were measured using A-scan ultrasonography on treatment day 1 at 12:00, and again on day 5 at 12:00; growth rate is defined as the change in axial length over 96 h. For quinpirole and pirenzepine, subsets (n's in Methods) of mid-day and evening groups were measured at 6 h intervals on day 5 (from 12:00 to 12:00) to obtain rhythm parameters for axial length and choroidal thickness; for atropine, only the mid-day group was measured. Refractions were measured on day 5 with a Hartinger's refractometer. For quinpirole and pirenzepine, mid-day injections were more effective at inhibiting ocular growth than evening (Exp-fellow: quinpirole: -68 vs 118 μm/96h; post-hoc Bonferroni p = 0.016; pirenzepine: 79 vs 215 μm/96h; p = 0.046). There were no between-group statistically significant differences for atropine. For quinpirole, the mid-day amplitude of the axial rhythm was smaller than for evening (95 vs 142 μm; p 0.05), but there were no time-dependent effects on the rhythms for pirenzepine. For atropine, the amplitude of the axial-length rhythm was significantly larger than that for pirenzepine at mid-day. We conclude that there is a phase-dependent efficacy for quinpirole and pirenzepine, with mid-day injections being most effective. There were no consistent time-dependent alterations in rhythm parameters for any of the drugs.
تدمد: 0014-4835
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b19159e43ac1e74feb328972d1a703b0Test
https://doi.org/10.1016/j.exer.2019.01.008Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....b19159e43ac1e74feb328972d1a703b0
قاعدة البيانات: OpenAIRE